An on-call app for 3:12 AM: a urology resident wrote 217 articles himself, 99 €/year

A urology resident in Innsbruck, Austria, built an app after his shifts: night-shift quick-reference cards, specialty articles written to guidelines, and nearly two thousand specialty exam questions, for 99 € a year. Within 9 days of launch it reached #5 on the Austrian medical Top Grossing chart. That ranking may reflect only a dozen or so subscriptions, but it shows something: a small tool made by doctors for peers, written to one country's guidelines and exams, has people willing to pay for it, and almost nobody is building it. Below: what it is, where the money comes from, how much the chart ranking is worth, and who could follow.

A 03:12 screenshot

The first App Store screenshot on the UroLotse site, captioned "Die Dienst-Liste um 03:12", the on-call list at 3:12 AM. Black background, a row of tags sorted by presenting complaint at the top: flank pain, gross hematuria, urinary retention, acute scrotum, fever, catheter problems, trauma, penile pain. Below, a red "act immediately" tier: autonomic dysreflexia, Fournier's gangrene, urinary retention, testicular torsion, hematuria with bladder tamponade, incarcerated phimosis.

The website explains why it's sorted by presenting complaint rather than diagnosis: "Because a call starts with a complaint, not a diagnosis." Opening a card expands only the "immediate checks" section by default, and the rest stays collapsed until you tap it. Dark mode is pure black, and the buttons are large for one-handed use.

Only someone who has worked nights would design this. Developer Felizian Lackner is a urology resident at the Tirol Kliniken university hospital in Innsbruck, listed on the hospital's resident roster, and he has papers on PubMed under his name. On the App Store, this is the only app under his name.

What it actually sells

One subscription, 9.99 €/month or 99 €/year, with a 7-day free trial, available once per Apple ID (official site, 11-06). What you get after subscribing, by the site's counts ("counted from the app files", as of November 2026):

Three details show it was designed around "would a doctor trust this": every line carries a source, and anything beyond the guidelines is tagged with a PMID; the questions are "derived from the articles, not invented", with every correct answer findable in an article inside the app, so no outside exam material is needed; no analytics, no tracking, no ads, and patient data entered into cards exists only while the card is open, then disappears when you close it.

Updates are fast. 11-06 has shipped 1.2 versions in just 10 days since launch: the whole app got an English version, an anticoagulation card was added, and two new bladder cancer perioperative studies, EV-303 and EV-304, were written into the articles (App Store release notes, 11-06).

Why now: the German-speaking gap is empty

Urology residents in German-speaking countries find that every tool they have falls a little short:

Austria's urology specialist exam and the European Board of Urology (EBU) written exam are taken together, and Germany has its own Facharztprüfung. Residents can't avoid either one, whether they need it on call or for the test. UroLotse puts both into one German-language app. Before it, no urology app in German-speaking markets combined on-call quick reference, guideline articles and an exam question bank.

How much the chart rank is worth

Start with the numbers (App Store Austria, medical category):

It has charted in only one storefront, Austria. Germany and Switzerland, no. Two things to keep in mind:

• The Austrian medical Top Grossing chart has a low bar. On the same day (11-06), the top 20 on that chart included an antibiotic handbook by a Vienna infectious-disease physician, and Medizingo and MSK Sono, both listed only 2026 years ago. Many of these are small apps made by doctors for other doctors. The #5 spot probably corresponds to a few 99 € annual subscriptions a day, my guess is single digits to a dozen-odd sales (inference, unverified).
• The timeline fits a trial-to-paid conversion. 10-29 hit #17 on the Top Free chart, the peak of acquaintance downloads in the first two days after launch. It first appeared on Top Grossing at 11-04, right after a 7-day trial period ended. Some of the first trial users probably paid for the annual plan (inference).

So "breaking out" is an overstatement. It's now a small product whose willingness to pay has been tentatively validated, but it hasn't scaled yet.

Where users come from

Almost entirely the author's own peer circle (inference, I found no public reshare posts).

• Colleagues and the society: it reached the top 20 Top Free within two days of launch, and only in Austria. It most likely spread through hospital colleagues and reshares in the Austrian Urological Society (ÖGU) circle. Austrian urology residents are a tiny community, so a handful of acquaintances can account for a big share of downloads.
• Instagram @urolotse: posting began 10-21, a week before launch, with clinical quiz questions ("A teenager with classic testicular torsion presentation, but Doppler shows normal flow. What next?") and on-call scenes like "the 3 a.m. phone call." By 11-06 it had only 35 followers and 0–1 likes per post. The traffic it brought is negligible.
• Website urolotse.at: well made, but the site is new, and searching "UroLotse" doesn't surface it near the top.
• No ad spend found. 0 mentions on X, and no media coverage.

In other words, almost nobody has seen it yet. That's good news: anyone who wants to follow this path isn't facing a crowd of copycats.

Where the money ceiling is

The ceiling for this business is clear, and it isn't high. In 2024 Germany had 3,583 practicing urologists (KBV statistics). Counting hospital physicians and residents, the German-speaking urology workforce is on the order of a few thousand to ten thousand people (estimate). If 1,000 of them pay the annual fee, that's about ¥99K a year. The list price includes VAT, and after Apple's 15% small-developer commission, take-home is roughly ¥70K (estimate).

For a doctor with a day job, that's a solid side income. For an indie developer hoping to go full-time on it, one specialty in one language can't carry the business. To grow, it has to go multilingual, multi-country, multi-specialty. The English version of 1.2 is a step in that direction.

If it were you

B: worth following, provided the team includes a practicing physician willing to write content over the long term. Willingness to pay is tentatively proven, and almost nobody knows about it. Competitors are either in English or too thin. The weaknesses are clear too: a single specialty is a small market, content requires a high bar, and there's medical liability. Someone without medical training can't just follow the steps and produce something that works.

• Who it suits: a resident or specialist plus a developer (or a doctor who can code themselves). You have to be sitting the specialty exam or doing night shifts yourself, so you know where colleagues get stuck at 3 a.m.
• Who it doesn't suit: anyone without medical training planning to mass-generate medical content with AI (doctors will spot it instantly and won't trust it, and you carry the liability when it's wrong); anyone aiming to make a full-time income from a single specialty.
• How to build it: Copy its skeleton and swap the grid: one specialty × one country's guidelines × one specialty board exam. You can change the specialty (anesthesia, emergency, pediatrics, cardiology; all of them have on-call work and board exams), or change the country and language (French-speaking regions, Italy, the Nordics, Japan, where English-language products with local guidelines don't reach). Keep the structure: on-call cards sorted by chief complaint, guideline articles with a source on every line, a question bank built from your own articles, plus spaced repetition and an annual subscription. Have enough content on day one. UroLotse already had 217 articles and 1946 questions by day 10 after launch, and peers can tell at a glance that someone serious built it.
• How to get users: this kind of product grows through peer word of mouth. Start by spreading it within your own department and resident groups, then move to specialty society annual meetings, resident training courses, and specialty exam study groups. Instagram with clinical quiz teasers can work for awareness, but don't expect it to drive volume. At ¥99 a year, it may be reimbursable or tax-deductible (inference); say so clearly in your marketing.
• When to move: not urgent, but don't wait too long. This cell is empty because whoever fills it has to know the field. Once a big platform like AMBOSS starts splitting content by specialty and exam, or the official EAU app adds a question bank and German, the gap closes. Based on what one specialty needs in content per year, starting to write now means being ready for the next exam season.
• What would show I got it wrong: ① UroLotse stays hovering around #20 on the Austrian medical Top Grossing chart through 2027 January, and even after the English version launches, it never charts in Germany, Switzerland, or English-speaking markets. That would mean people outside the circle aren't buying. ② Ratings are still single digits in early next year, which would mean the paying users are just the few dozen people the author knows. ③ The author slows down on updates (residents rarely manage to keep up), which would show that one person can't sustain this much content. Anyone following this path needs to decide first who will write over the long term.